Ping Cao from Alpharetta, GA, age 68

Resumes

Vice President Of Business Development

view source

Location:

New York, NY

Industry:

Pharmaceuticals

Work:

Abzena Jul 2017 - Jul 2018
Senior Director of Business Development
Henlius Biotech Co. Ltd. Jul 2017 - Jul 2018
Vice President of Business Development
Bristol-Myers Squibb Jun 1, 2009 - 2017
Associate Director, Contract Manufacturing Operation, Global External Manufacturing and Alliance
Ferro Corporation Oct 2008 - May 2009
Senior Business Development Manager, Api Manufacturing
Tyger Scientific Inc. 2004 - 2008
Director of Sales and Marketing, Contract Manufacturing and Contract Research Service

Education:

Michigan State University 2001 - 2004
Masters, Organic Chemistry Tianjin University 1996 - 1999
Masters, Chemical Engineering Tianjin University
Bachelors, Materials Science, Engineering

Skills:

Pharmaceutical Industry
Cross Functional Team Leadership
New Business Development
Technology Transfer
Contract Negotiation
Project Management
Marketing Strategy
Biopharmaceuticals
Management
Sales Management
Bilingual
Drug Development
Business Development
Outsourcing Management
International Sales
Forecasting
Training
Leadership
Sales
Communication
Biotechnology
Strategy
Life Sciences
Drug Discovery
Licensing
Drug Product Manufacturing
Content Marketing
Public Relations
Public Speaking
B2C Marketing
Brand Management
Accounting
Corporate Finance
Investments
Business Strategy
Small Business Financial Management

Languages:

English
Mandarin

Certifications:

Certified Licensing Professionals
Certification of Achievement – Alliance Management
Certified Licensing Professionals, Inc., License 2630

Ping Cao

view source

Location:

Stony Brook, NY

Industry:

Research

Work:

Stony Brook University 2008 - Dec 2012
Research Assistant
Nanjing University Sep 2005 - Jun 2007
Research Assistant

Education:

Stony Brook University 2007 - 2012
Doctorates, Doctor of Philosophy, Biology, Biophysics, Philosophy, Chemistry Nanjing University 2001 - 2007
Master of Science, Masters, Bachelors, Chemistry

Skills:

Dls
Mass Spectrometry
Protein Chemistry
Hplc
Fplc
Lc Ms
Peptide Synthesis
Biophysics
Chemistry
Uv/Vis
Molecular Biology
Purification
Fluorescence
Cell Biology
Cell
Cell Culture
Western Blotting
Tissue Culture
Protein Purification

Marketing Manager

view source

Location:

New York, NY

Industry:

Chemicals

Work:

Tyger
Marketing Manager

Education:

Michigan State University 2001 - 2004

Registered Nurse

view source

Location:

Tarrytown, NY

Industry:

Real Estate

Work:

Wingate and Associates
Registered Nurse

Ping Cao

view source

Ping Cao

view source

Ping Cao

view source

Ping Cao Stony Brook, NY

view source

Work:

Stony Brook University

2008 to 2000
Research Assistant NYU Medical Center, School of Medicine
New York, NY
Apr 2011 to May 2012
Visiting Scientist

Education:

Stony Brook University
2007 to 2000
Ph.D. in Chemistry School of Life Science, Nanjing University
2005 to 2007
M.S. Nanjing University
2001 to 2005
B.S. in Department of Chemistry

Skills:

protein and peptide chemistry, solid-phase peptide synthesis, expression, purification and characterization of proteins fluorescence spectroscopy. HPLC, gel filtration chromatography, UV-Vis absorption spectroscopy, LC/MS, MALDI-TOF mass spectrometry, analytical ultracentrifugation, dynamic light scattering, circular dichroism and transmission electron microscopy. cell and tissue cultures, molecular and cellular assays. computer skills in biochemistry related programs and general data processing and graphic programs.

Us Patents

Islet Amyloid Polypeptides With Improved Solubility
view source
US Patent:

20180319860, Nov 8, 2018
Filed:

Jul 11, 2018
Appl. No.:

16/032328
Inventors:

- Albany NY, US
Hui WANG - East Setauket NY, US
Ping CAO - New York NY, US
Andisheh ABEDINI - New York NY, US
Assignee:

The Research Foundation for The State University of New York - Albany NY
International Classification:

C07K 14/575
C07K 14/00
A61K 38/28
A61K 38/22
A61K 38/00
Abstract:

Isolated non-naturally occurring, mutant-human islet amyloid polypeptides (hIAPP) are disclosed. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. Methods and compositions for treating amyloid-based disease in a subject in need thereof, by administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof are also disclosed.

Islet Amyloid Polypeptides With Improved Solubility
view source
US Patent:

20170051032, Feb 23, 2017
Filed:

May 1, 2015
Appl. No.:

15/308138
Inventors:

- Albany NY, US
Hui WANG - East Setauket NY, US
Ping CAO - New York NY, US
Andisheh ABEDINI - New York NY, US
Assignee:

THE RESEARCH FOUNDATION FOR THE STATE UNIVERSITY OF NEW YORK - Albany NY
International Classification:

C07K 14/575
A61K 38/28
A61K 38/22
C07K 14/00
Abstract:

The present disclosure provides for isolated non-naturally occurring, mutant-human IAPP polypeptides. These polypeptides can be formulated or co-formulated at physiological pH, which enable the polypeptides of the instant disclosure to be delivered to a subject having an amyloid-based disease in a single injection with an insulin agent. The present disclosure also provides methods and compositions for treating amyloid-based disease in a subject in need thereof, comprising administering an effective amount of an isolated, mutant-hIAPP polypeptide, including formulations or co-formulations thereof.